Stock Price Quote

AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE482.85-3.4 (-0.7 %)
PREV CLOSE ( ) 486.25
OPEN PRICE ( ) 489.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 86967
TODAY'S LOW / HIGH ( )477.30 489.90
52 WK LOW / HIGH ( )389.7 838
NSE482.95-3 (-0.62 %)
PREV CLOSE( ) 485.95
OPEN PRICE ( ) 485.00
BID PRICE (QTY) 482.95 (500)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1733486
TODAY'S LOW / HIGH( ) 477.05 488.35
52 WK LOW / HIGH ( )389.35 838
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 26-12 1986
Management Info
K Ragunathan - Chairman N Govindarajan - Managing Director
Registered Office

Address Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone +91-040-66725000

Email info@aurobindo.com

Website www.aurobindo.com

Registrars Details
KFIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

03Jan Aurobindo Pharma’s arm recalling Mirta
Aurobindo Pharma’s arm -- Aurobindo Pharma USA Inc is voluntarily recall..
03Jan Aurobindo Pharma slips as its arm reca
Aurobindo Pharma is currently trading at Rs. 460.70, down by 1.30 points..
13Dec Aurobindo Pharma’s arm recalls 59.5 th
Aurobindo Pharma’s arm -- AuroMedics Pharma LLC has initiated recall of..
12Dec Aurobindo Pharma informs about change
Aurobindo Pharma has informed that the Company has been informed by its..
29Nov IL&FS Engineering, Aurobindo Pharma an
IL&FS Engineering and Construction Company’s subsidiary -- Bangalore..

Financials

in Millions
QTR Sep 19 ANNUAL 19
Net Profit3981.315297.3
Gross Profit 5220.6 19646.2
Operating Profit 6648.525085.7
Net Sales 32216.6122578.9

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Ajanta Pharma (BSE)
peergroup  1198.70 (5.73%)
M.Cap ( in Cr)10460.01
Abbott India (BSE)
peergroup  12639.40 (0.50%)
M.Cap ( in Cr)26857.84
Dr. Reddys Lab (BSE)
peergroup  3058.00 (0.80%)
M.Cap ( in Cr)50812.69
Procter&Gamble Healt (BSE)
peergroup  4331.70 (0.57%)
M.Cap ( in Cr)7190.35
Alkem Laboratories (BSE)
peergroup  2360.20 (0.99%)
M.Cap ( in Cr)28219.73

Shareholding Pattern

PROMOTERS 51.87%
NON-INSTITUTION 13.53%
MUTUAL FUNDS/UTI 12.78%
FI/BANKS/INSURANCE 0.4%
GOVERNMENT 0%
FII 0%

About Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd. was incorporated in the year 26-12-1986. Its today's share price is 482.85. Its current market capitalisation stands at Rs 28292.05 Cr. In the latest quarter, company has reported Gross Sales of Rs. 0 Cr and Total Income of Rs.0 Cr. The company's management includes B Adi Reddy, Savita Mahajan, Avnit Bimal Singh, M Sitarama Murty, PV Ramprasad Reddy, P Sarath Chandra Reddy, M Madan Mohan Reddy, M Sivakumaran, N Govindarajan, K Nithyananda Reddy, K Ragunathan.

It is listed on the BSE with a BSE Code of 524804 , NSE with an NSE Symbol of AUROPHARMA and ISIN of INE406A01037. It's Registered office is at Plot No. 2,Maitrivihar ,AmeerpetHyderabad-500038, Telangana. Their Registrars are ACC Ltd. It's auditors are BSR & Associates LLP, K Nagaraju & Associates, SR Batliboi & Associates, SR Batliboi & Associates LLP, SR Batliboi & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X